Approval · Notice of Compliance 10149 · 2009
IBUPROFEN: Notice of Compliance 10149
Issued April 14, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10149
- Date
- April 14, 2009
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
- Therapeutic class
- Analgesic / antipyretic agent
- Canadian reference product
- MOTRIN (Mcneil Consumer Healthcare)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUPROFEN | Not yet assigned | — |
| IBUPROFEN (CAPLET) | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB